Dog-Assisted Therapy in Neurorehabilitation of Children with Severe Neurological Impairment: An Explorative Study.


Journal

Neuropediatrics
ISSN: 1439-1899
Titre abrégé: Neuropediatrics
Pays: Germany
ID NLM: 8101187

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 17 3 2020
medline: 5 6 2021
entrez: 17 3 2020
Statut: ppublish

Résumé

Dog-assisted therapy (DAT) is increasingly applied in neurorehabilitation of patients with severe neurological impairments. To date, there are only anecdotal reports investigating its effects. This study was aimed to evaluate the potential of DAT in pediatric inpatient neurorehabilitation for severely neurologically impaired children and adolescents, to identify characteristics of patients receiving this therapy, characteristics of the therapy sessions, and to evaluate feasibility and extent of goal achievement. We retrospectively analyzed 850 DAT sessions performed between 2010 and 2017 at an inpatient neurorehabilitation center. The dataset included 196 children and adolescents (Md = 5.50, 0.58-20.33 years) suffering from severe neurological impairments (disorders of consciousness in 37 patients) of various etiologies. We extracted information regarding patient and session characteristics, analyzed the predefined goals with content analysis, and examined to what extent the goals were met during DAT. Data were analyzed using descriptive statistics. Patients received an average of 4.34 therapy sessions. A total of 247 of 392 predefined goals (63%) were reached during DAT. The most frequently achieved goal was "enhancing fun" (83%), followed by "establishing contact and communication" (81%), and "relaxation" (71%). Only one critical incident regarding the dogs' safety occurred. DAT is a feasible approach and appears to facilitate emotional, social, and psychological goals in children and adolescents with severe neurological impairment.

Sections du résumé

BACKGROUND
Dog-assisted therapy (DAT) is increasingly applied in neurorehabilitation of patients with severe neurological impairments. To date, there are only anecdotal reports investigating its effects.
OBJECTIVES
This study was aimed to evaluate the potential of DAT in pediatric inpatient neurorehabilitation for severely neurologically impaired children and adolescents, to identify characteristics of patients receiving this therapy, characteristics of the therapy sessions, and to evaluate feasibility and extent of goal achievement.
METHODS
We retrospectively analyzed 850 DAT sessions performed between 2010 and 2017 at an inpatient neurorehabilitation center. The dataset included 196 children and adolescents (Md = 5.50, 0.58-20.33 years) suffering from severe neurological impairments (disorders of consciousness in 37 patients) of various etiologies. We extracted information regarding patient and session characteristics, analyzed the predefined goals with content analysis, and examined to what extent the goals were met during DAT. Data were analyzed using descriptive statistics.
RESULTS
Patients received an average of 4.34 therapy sessions. A total of 247 of 392 predefined goals (63%) were reached during DAT. The most frequently achieved goal was "enhancing fun" (83%), followed by "establishing contact and communication" (81%), and "relaxation" (71%). Only one critical incident regarding the dogs' safety occurred.
CONCLUSION
DAT is a feasible approach and appears to facilitate emotional, social, and psychological goals in children and adolescents with severe neurological impairment.

Identifiants

pubmed: 32176927
doi: 10.1055/s-0040-1708545
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-274

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None.

Auteurs

Karin Hediger (K)

Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, Switzerland.
REHAB Basel, Clinic for Neurorehabilitation and Paraplegiology, Basel, Switzerland.
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.

Friederike Boek (F)

Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, Switzerland.

Julia Sachers (J)

Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, Switzerland.

Ulrike Blankenburg (U)

Center für Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogatreuth, Germany.

Evelyn Antonius-Kluger (E)

Center für Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogatreuth, Germany.

Bettina Rist (B)

Center für Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogatreuth, Germany.

Martina Schaudek (M)

Center für Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogatreuth, Germany.

Martin Staudt (M)

Center für Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogatreuth, Germany.
Department Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany.

Gerhard Kluger (G)

Center für Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Clinic, Vogatreuth, Germany.
Research Institute "Rehabilitation, Transition, Palliation", Paracelsus Medicine University, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH